Conclusion GLP-1 microdosing sits between biological plausibility and clinical uncertainty
GLP-1 increases insulin secretion in response to glucose and improves insulin sensitivity, suppresses glucagon release, and reduces appetite [7, 54]
Why Physician Supervision Matters GLP 1 medications can be incredibly effective, but only when managed correctly
doi: 10.1053/j.gastro.2005.02.005 53 MorganA
This receptor profile produces broader metabolic effects than semaglutide or tirzepatide, including appetite suppression, improved insulin sensitivity, and enhanced fat oxidation
PubMed Sinha, D.K., Balasubramanian, A., Tatem, A.J., Rivera-Mirabal, J., Yu, J., Kovac, J., Pastuszak, A.W., & Lipshultz, L.I